Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
33 studies found for:    " November 19, 2008":" December 19, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)
Condition: HIV
Intervention: Biological: Dendritic Cell Vaccine
22 Completed
Has Results
Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
23 Unknown  Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Conditions: Dry Eye Syndromes;   HIV Seropositivity
Interventions: Drug: cyclosporine and sodium carboximethycellulose;   Drug: sodium carboximethycellulose
24 Completed A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
Conditions: Lymphoma, AIDS Related;   HIV Infections
Intervention: Drug: R-EPOCH and cART
25 Recruiting A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Condition: Human Immuno Deficiency (HIV) Infection
Interventions: Drug: Rilpivirine;   Drug: Zidovudine;   Drug: Abacavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Lamivudine;   Drug: Emtricitabine
26 Completed Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)
Conditions: HIV;   Hepatitis C
Interventions: Behavioral: Motivational interviewing;   Behavioral: Educational intervention
27 Completed Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients
Conditions: HIV;   Tuberculosis;   Latent Tuberculosis Infection
Intervention: Other: QTF-TB Gold and T-SPOT TB
28 Completed A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Conditions: Human Immunodeficiency Virus;   Human Papillomavirus- 6, 11, 16, 18;   Adolescent;   Papillomavirus Vaccines
Interventions: Biological: Gardisil;   Behavioral: Survey
29 Active, not recruiting Safety And Efficacy Of Rifabutin In HIV Patients
Conditions: Non-tuberculous Mycobacterial Diseases (Including MAC Disease);   Tuberculosis;   Inhibition of Disseminated Mycobacterium Avium Complex (MAC) Disease Associated With HIV Infections
Intervention: Drug: rifabutin
30 Completed TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
Conditions: Pharmacokinetics;   Bioavailability;   HIV-1
Intervention: Drug: TMC278
31 Completed
Has Results
Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications
Conditions: HIV;   Cardiovascular Diseases;   Atherosclerosis
Interventions: Drug: Pentoxifylline;   Drug: Placebo
32 Completed HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse
Condition: Risk Reduction
Interventions: Behavioral: Information-motivation-behavior skills and cognitive processing therapy;   Behavioral: Pre and Post HIV-Test Counseling
33 Completed Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
Conditions: Buprenorphine;   HIV;   Drug Abuse;   Drug Addiction;   Drug Dependence;   Drug Use Disorders;   Drug Use Disorder;   Substance Abuse;   Opiate Addiction;   Substance-related Disorders
Interventions: Other: Services will be provided at one site;   Other: Services remain dispersed; i.e., not centralized to one-location or provider.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page   
Study has passed its completion date and status has not been verified in more than two years.